DCIS (Ductal Carcinoma in Situ) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

DCIS: Biosignature Helps Guide Post-Lumpectomy Decisions DCIS: Biosignature Helps Guide Post-Lumpectomy Decisions
A new biosignature tool helps with treatment decisions after lumpectomy for ductal carcinoma in situ (DCIS), eg, by identifying those who can skip radiotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 17, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Radiotherapy appears to be most cost-effective option for standard-risk DCIS
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2021 Category: Drugs & Pharmacology Source Type: news

Surgical Technique May Cut Positive Margin Rates in DCIS
Cavity shave margin resections for pure ductal carcinoma in situ may lower risk for positive margins (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 21, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Journal, Source Type: news

Surgical Technique May Cut Positive Margin Rates in DCIS
WEDNESDAY, April 21, 2021 -- Cavity shave margin (CSM) resections may reduce positive margin rates in patients with pure ductal carcinoma in situ (DCIS), according to a study published in the April issue of the Journal of the American College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 21, 2021 Category: Pharmaceuticals Source Type: news

Surgical technique recommended for DCIS patients
New research suggests removing additional tissue around the tumor cavity fo...Read more on AuntMinnie.comRelated Reading: DBT shows promise in new study with lower interval cancer rates Breast screening rates rebound after COVID, but deficit remains Estrogen receptor tied to outcomes in DCIS PET aids in treatment of metastatic breast cancer patients Review supports surgical excision for FEA breast lesions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 6, 2021 Category: Radiology Source Type: news

Surgical technique may reduce positive margin rate in breast cancer patients with DCIS
(Wake Forest Baptist Medical Center) According to the American Cancer Society, a noninvasive breast cancer called ductal carcinoma in situ (DCIS) accounts for approximately one of every four new breast cancer cases in the United States. If left untreated, DCIS has the potential to evolve into invasive cancer, so many patients choose to have breast-conserving surgery or mastectomy after a diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2021 Category: Cancer & Oncology Source Type: news

Estrogen receptor tied to outcomes in DCIS
The estrogen receptor plays a key role in predicting long-term outcomes in patient...Read more on AuntMinnie.comRelated Reading: SNMMI confirms Medicare reimbursement error for Cerianna PET aids in treatment of metastatic breast cancer patients SNMMI, Zionexa call out CMS for reimbursement error Black women die more frequently from breast cancer AI tool beats traditional breast cancer risk assessments FES-PET could predict endometrial cancer outcomes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2021 Category: Radiology Source Type: news

More accurate method to predict long term outcomes for pre-invasive breast cancer
(Queen Mary University of London) A study by Queen Mary University of London researchers, funded by Cancer Research UK, confirms the role of the oestrogen receptor biomarker in ductal carcinoma in situ and presents a new and more accurate method to predict long term outcomes for this pre-invasive stage of breast cancer. The study is published in Clinical Cancer Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 16, 2021 Category: International Medicine & Public Health Source Type: news

PreludeDx touts study on DCIS results
Molecular diagnostics developer PreludeDx presented a study at the Miami Breas...Read more on AuntMinnie.comRelated Reading: Prelude highlights ASTRO data on breast cancer risk test (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 5, 2021 Category: Radiology Source Type: news

Moffitt researchers identify how cancer cells adapt to survive harsh tumor microenvironments
(H. Lee Moffitt Cancer Center& Research Institute) To better understand the conditions that select for the Warburg Effect and the mechanisms where cells can express this metabolic adaptation, Moffitt researchers subjected nonmalignant cells to the harsh tumor microenvironment that is present during early carcinogenesis, known as ductal carcinoma in situ. In a new research article published in the Proceedings of the National Academy of Sciences, the Moffitt team shows that these conditions select for cells to express a Warburg Effect. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 19, 2021 Category: Cancer & Oncology Source Type: news

Breast density can predict lymphedema risk
Breast density calculations derived from mammograms can be used to predict...Read more on AuntMinnie.comRelated Reading: Textural analysis improves breast MRI's accuracy Breast cancer survivors fail to pursue surveillance Sentinel lymph node biopsy unnecessary for DCIS Breast cancer takes financial toll beyond treatment JCO releases new sentinel node biopsy guidelines (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 12, 2020 Category: Radiology Source Type: news

Interobserver Variability in DCIS of the Breast Interobserver Variability in DCIS of the Breast
This study demonstrated that histopathologic assessment of DCIS of the breast is characterized by considerable interobserver variability. What can be done to improve interobserver agreement?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 10, 2020 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Some types of HRT more risky for breast cancer
A new prospective study from the U.K. linked the use of hormone replacement...Read more on AuntMinnie.comRelated Reading: High-risk breast clinic helps deliver specialized care New breast cancer risk model includes 93 relationships Years later, DCIS tied to more imaging but not anxiety CDC: Breast cancer death rate declines, but not equally Infertility therapy may boost breast density (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 6, 2020 Category: Radiology Source Type: news

Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
Risk higher in first five years of follow - up for those treated with breast - conserving surgery alone (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 16, 2020 Category: Cancer & Oncology Tags: Gynecology, Oncology, Surgery, Conference News, Source Type: news

Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
FRIDAY, Oct. 16, 2020 -- For women with ductal carcinoma in situ (DCIS), the risk for developing subsequent ipsilateral in situ (iDCIS) and invasive breast cancer (iBC) is lower for those receiving breast-conserving surgery (BCS) and radiotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news